Information message

In order to see all the search results and access content, you must log in. Please use the Log-in button at the top of the page.

Displaying results 1 - 11 of 11
Metabolism, Alcohol & Toxicity

Introduction and presentation of the NAFLD patient guideline

Webcasts
View
Metabolism, Alcohol & Toxicity

The user perspective

Webcasts
View
Metabolism, Alcohol & Toxicity

Changing the models of care

Webcasts
View
Metabolism, Alcohol & Toxicity

A practical example from the guideline

Webcasts
View
Metabolism, Alcohol & Toxicity

A multidisciplinary patient-centred approach

Webcasts
View
Metabolism, Alcohol & Toxicity
Non-alcoholic fatty liver disease: A patient guideline - GE version

Non-alcoholic fatty liver disease: A patient guideline - GE version

PDF
View
Metabolism, Alcohol & Toxicity
EASL Policy Statement: Reducing alcohol harms

EASL Policy Statement: Reducing alcohol harms

PDF
View
Liver Tumours
EASL Policy Statement: risk-based surveillance for hepatocellular carcinoma among patients with cirrhosis

EASL Policy Statement: risk-based surveillance for hepatocellular carcinoma among patients with cirrhosis

PDF
View
Liver Tumours
EASL Studio S1 E1: Liver Cancer Awareness Month

EASL Studio S1 E1: Liver Cancer Awareness Month

EASL Studio
View
Liver Tumours
EASL Studio Special Edition: Highlights of Liver Cancer Summit 2022

EASL Studio Special Edition: Highlights of Liver Cancer Summit 2022

EASL Studio
View
Liver Tumours
EASL Patient Synergies Roundtable Discussion: Improving the Lives of Liver Cancer Patients

EASL Patient Synergies Roundtable Discussion: Improving the Lives of Liver Cancer Patients

Webcasts
View
Displaying results 1 - 11 of 11